A pooled analysis of the duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine

MT Bretscher, P Dahal, J Griffin, K Stepniewska, Q Bassat, E Baudin, U D’Alessandro, AA Djimde, G Dorsey, E Espié, B Fofana, R González, E Juma, C Karema, E Lasry, B Lell, N Lima, C Menéndez, G Mombo-Ngoma, C Moreira, F Nikiema, JB Ouédraogo, SG Staedke, H Tinto, I Valea, A Yeka, AC Ghani, PJ Guerin, LC Okell
doi: https://doi.org/10.1101/19002741

Article Information

doi 
https://doi.org/10.1101/19002741
History 
  • July 20, 2019.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. MT Bretscher1,*,†,
  2. P Dahal2,3,
  3. J Griffin4,
  4. K Stepniewska2,3,
  5. Q Bassat5,6,7,8,9,
  6. E Baudin10,
  7. U D’Alessandro11,
  8. AA Djimde12,
  9. G Dorsey13,
  10. E Espié10,14,
  11. B Fofana12,
  12. R González5,6,
  13. E Juma15,
  14. C Karema16,17,
  15. E Lasry18,
  16. B Lell19,20,
  17. N Lima21,
  18. C Menéndez5,6,
  19. G Mombo-Ngoma20,22,23,
  20. C Moreira2,3,
  21. F Nikiema24,
  22. JB Ouédraogo24,
  23. SG Staedke25,
  24. H Tinto26,
  25. I Valea26,
  26. A Yeka27,
  27. AC Ghani1,
  28. PJ Guerin2,3 and
  29. LC Okell1,*
  1. 1MRC Centre for Global Infectious Disease Analysis, Department of Infectious Diseases, Imperial College London, London, UK
  2. 2WorldWide Antimalarial Resistance Network (WWARN), Oxford, UK
  3. 3Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
  4. 4School of Mathematical Sciences, Queen Mary University of London, London, UK
  5. 5Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique
  6. 6ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain
  7. 7ICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain
  8. 8Pediatric Infectious Diseases Unit, Pediatrics Department, Hospital Sant Joan de Déu (University of Barcelona), Barcelona, Spain
  9. 9Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
  10. 10Epicentre, Paris, France
  11. 11MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia
  12. 12Malaria Research and Training Center, University of Science, Techniques and Technologies of Bamako, Bamako, Mali
  13. 13Department of Medicine, University of California San Francisco, San Francisco, USA
  14. 14GSK Vaccines, R&D Center, Clinical and Epidemiology Department, Wavre, Belgium
  15. 15Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya
  16. 16Swiss Tropical and Public Health Institute, Basel, Switzerland
  17. 17University of Basel, Basel, Switzerland
  18. 18Medecins Sans Frontieres-OCBA, Barcelona, Spain
  19. 19Department of Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Vienna, Austria
  20. 20Centre de Recherches Medicales de Lambarene, Lambarene, Gabon
  21. 21Department of Paediatrics, University of Calabar, Calabar, Nigeria
  22. 22Institute for Tropical Medicine, University of Tubingen, Tubingen, Germany
  23. 23Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine & I. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  24. 24Institut de Recherche en Science de la Sante, Bobo-Dioulasso, Burkina Faso
  25. 25Department of Clinical Research, Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
  26. 26Institut de Recherche en Science de la Sante, Nanoro, Burkina Faso
  27. 27Uganda Malaria Surveillance Project, Kampala, Uganda
  1. ↵*Corresponding authors. email: l.okell{at}imperial.ac.uk
  2. ↵†Present Address: F. Hoffmann-La Roche Ltd, Basel, Switzerland
Back to top
Posted July 20, 2019.
Download PDF
Data/Code
Email
A pooled analysis of the duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine
MT Bretscher, P Dahal, J Griffin, K Stepniewska, Q Bassat, E Baudin, U D’Alessandro, AA Djimde, G Dorsey, E Espié, B Fofana, R González, E Juma, C Karema, E Lasry, B Lell, N Lima, C Menéndez, G Mombo-Ngoma, C Moreira, F Nikiema, JB Ouédraogo, SG Staedke, H Tinto, I Valea, A Yeka, AC Ghani, PJ Guerin, LC Okell
medRxiv 19002741; doi: https://doi.org/10.1101/19002741
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area